Mucus plugs and lung scarring in COPD patients having lung cancer surgery
Part of Lungs & breathing clinical trials.
This study looks at whether mucus plugs (thick mucus blocking the airways) in people with COPD might lead to more lung scarring after lung cancer surgery. It compares lung tissue from people with COPD to those with normal lungs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older
- You are planning to have surgery to remove lung cancer, and the doctor will get a sample of lung tissue at least 2 inches away from the tumor
- You either have COPD (based on a breathing test) or have normal lung function with no history of COPD
- You do not have other lung diseases (like idiopathic pulmonary fibrosis, pneumoconiosis, or active tuberculosis)
- You have no active lung infection (like pneumonia) and have not received chemotherapy or radiation before surgery
- You are not on long-term high-dose steroids (more than 20 mg of prednisone daily for over 4 weeks) and are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects lung tissue samples during planned surgery to look at the cells and genes involved in COPD. It aims to understand why the disease gets worse over time.
This study tests whether special stem cells can help repair lung damage in people with COPD. It may help us understand how to improve lung function for those who smoke or have smoked.
This study looks at how mucus plugs affect air flow in the lungs. It may help find new ways to treat people with lung conditions like cystic fibrosis, severe asthma, COPD, or bronchiectasis.
This study looks at specific lung cells (called alveolar cells) to understand how smoking and chronic lung disease may change them. You may be invited if you are having lung surgery and can safely take part.
This study looks at COPD in people who are already getting lung cancer screening. If you have COPD or a high risk for it, joining this observational trial may help researchers learn more about your condition.
This trial studies blood and tissue samples from people with COPD, IPF, or lung cancer to find markers that can help diagnose and predict these conditions. It aims to discover why some lung diseases progress to cancer.
Hear when a new Lung Fibrosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.